Pityriasis Lichenoides Et Varioliformis Acuta Latest Advances

Efficacy and safety of a modified azithromycin regimen in pityriasis lichenoides chronica: a case series of six patients.

Journal: Italian journal of dermatology and venereology

Published: January 21, 2026

Pityriasis lichenoides: a university department long-term follow-up study.

Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica

Published: December 20, 2025

Successful Treatment of Refractory Pityriasis Lichenoides Chronica with Upadacitinib in Two Patients.

Journal: Indian journal of dermatology

Published: November 20, 2025

Bullous pityriasis lichenoides et varioliformis acuta successfully treated with upadacitinib.

Journal: JAAD case reports

Published: September 25, 2025

Apremilast in the treatment of pityriasis lichenoides et varioliformis acuta: a case report.

Journal: The Journal of dermatological treatment

Published: September 18, 2025

Incomplete Susac Syndrome With Recurrent Retinal Occlusions and Vertigo: A Case of Early Immunosuppressive Success.

Journal: Cureus

Published: August 12, 2025

A pediatric case of human herpesvirus 6-associated pityriasis lichenoides et varioliformis acuta.

Journal: JAAD case reports

Published: July 24, 2025

Intertriginous Pityriasis Lichenoides Chronica: An Atypical Presentation.

Journal: Annals of African medicine

Published: July 13, 2025

Febrile Ulceronecrotic Mucha-Habermann Disease in a 22-Month-Old Boy: A Case Presentation and Literature Review.

Journal: The American Journal of dermatopathology

Published: June 25, 2025

The role of phototherapy in pediatric dermatology.

Journal: Anais brasileiros de dermatologia

Published: May 15, 2025

Successful treatment of pityriasis lichenoides et varioliformis acuta with stapokibart: a case report.

Journal: Frontiers in medicine

Published: April 20, 2025

Rare Presentation of Pityriasis Lichenoides et Varioliformis Acuta: A Case of Mucosal and Face Involvement in a 15-Year-Old Male.

Journal: Clinical case reports

Published: April 18, 2025